Delivery Order SPE2DB25D3201-SPE2DB25FNTWN

Award Date 6/12/25
Potential Completion Date 7/7/25
Potential Value $24K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a major pharmaceutical distribution company. The $16,873.86 firm fixed-price delivery order is for the supply of TASIGNA 150 MG CAPSULE 28S, a prescription medication. This award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as the primary...
This federal contract award, valued at $5,819.01, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of TASIGNA 150 MG CAPSULE 28S, a pharmaceutical product. The contract has an ultimate completion date of March 24, 2025 and is a Firm Fixed Price contract. The contract was not set aside for any specific business type. Amerisourcebergen Drug Corp...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $23,276.04 Firm Fixed Price Delivery Order contract is for the supply of TASIGNA 150 MG CAPSULE 28S, a specialty medication. The contract has a period of performance through March 13, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $12,015.80, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567751543 ! TASIGNA 150 MG CAPSULE 28S, a pharmaceutical product. The contract has an ultimate completion date of April 21, 2025 and is a Firm Fixed Price Delivery Order. The contract was not set aside for any specific business type. Amerisourcebergen Drug Corp...
This federal contract award, valued at $5,819.01, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, and it covers the supply of TASIGNA 150 MG CAPSULE 28S, a pharmaceutical product, to support military healthcare programs. The contract has an ultimate completion date of January 28, 2025, and it is not designated as a...
This federal contract award from the Defense Logistics Agency (DLA) is a delivery order with a firm fixed price of $11,638.02 and a completion date of March 25, 2025. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, to supply TASIGNA 150 MG CAPSULE 28S. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office division. The $5,624.62 firm fixed-price delivery order is for the supply of TASIGNA 150 MG CAPSULE 28S to support federal healthcare programs. The contract has an ultimate completion date of August 26, 2024. Amerisourcebergen is a major pharmaceutical distributor that has been awarded numerous indefinite delivery contracts (IDCs) by the DLA and other...
This federal contract award to AmerisourceBergen Drug Corp's Corporate Office division is a delivery order valued at $16,873.86 for the supply of TASIGNA 150 MG CAPSULE 28S, a pharmaceutical product. The award was made by the Defense Logistics Agency (DLA), a defense agency, with a performance period through September 4, 2024. This delivery order is issued under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999 between AmerisourceBergen and DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the delivery of TASIGNA 150 MG CAPSULE 28S. The $5,624.62 firm fixed price delivery order has an ultimate completion date of April 29, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is for the delivery of TASIGNA 150 MG CAPSULE 28S, a pharmaceutical product, to support the Defense Logistics Agency (DLA) Troop Support Medical program. The contract, valued at $5,624.62, is a Firm Fixed Price Delivery Order with a completion date of November 6, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA, valued at $999,999,999...
  • SPE2DB25D3201
    Indefinite Delivery Contract
  • SPE2DB25D3201-SPE2DB25FNTWN
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $24,031.60 fixed-price delivery order is for the supply of TASIGNA 150 MG CAPSULE 28S, a pharmaceutical product. This order is not designated as a set-aside contract.

Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00. This prime contract, designated as SPE2DX, provides a comprehensive global pharmaceutical support vehicle with a performance period extending through December 2026. The IDC enables the company to supply a vast range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard.

Generated 9/11/25, 11:06 AM